Side-by-side comparison of AI visibility scores, market position, and capabilities
Las Vegas gaming and hospitality (NYSE: MGM) at record $17.24B 2024 revenue (+6.7%); Las Vegas Strip $8.82B, MGM China $4.02B (+27.6%) record 15.8% share, BetMGM ~$2.4B net revenue competing with Caesars and Las Vegas Sands.
MGM Resorts International is a Las Vegas, Nevada-based global gaming, hospitality, and entertainment company — publicly traded on the New York Stock Exchange (NYSE: MGM) as an S&P 500 Consumer Discretionary component — owning and operating a portfolio of destination casino resorts and hotels on the Las Vegas Strip, across the United States in regional markets, and in Macau, China through approximately 55,000 employees. In fiscal year 2024, MGM Resorts reported record consolidated net revenues of $17.24 billion (+6.66% from 2023), the highest annual revenue in company history, with Las Vegas Strip Resorts generating $8.82 billion, Regional Operations generating $3.72 billion, and MGM China contributing $4.02 billion (+27.6% year-over-year) as Macau continued its full recovery from COVID restrictions and market share at MGM China reached an all-time high of 15.8%. CEO Bill Hornbuckle leads MGM's diversified gaming and hospitality strategy across three platforms: Las Vegas (Bellagio, MGM Grand, Aria, Park MGM, Mandalay Bay, New York-New York, Excalibur, Luxor), Regional (Borgata in New Jersey, MGM National Harbor in Maryland, MGM Grand Detroit, MGM Northfield Park in Ohio), and International (MGM Macau and MGM Cotai in China). MGM's BetMGM joint venture (50/50 with UK-based Entain plc) is one of the two largest US online sports betting and iGaming platforms, generating over $2.4 billion in net revenue and approaching profitability as US sports betting regulations expand state by state.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.